Esther M. John

ORCID: 0000-0003-3259-8003
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • BRCA gene mutations in cancer
  • Cancer Risks and Factors
  • Genetic Associations and Epidemiology
  • Nutrition, Genetics, and Disease
  • Global Cancer Incidence and Screening
  • Nutritional Studies and Diet
  • Ovarian cancer diagnosis and treatment
  • Genetic factors in colorectal cancer
  • Cancer Genomics and Diagnostics
  • Breast Cancer Treatment Studies
  • Prostate Cancer Treatment and Research
  • Estrogen and related hormone effects
  • Genomic variations and chromosomal abnormalities
  • DNA Repair Mechanisms
  • Colorectal Cancer Screening and Detection
  • Cancer-related molecular mechanisms research
  • RNA modifications and cancer
  • Epigenetics and DNA Methylation
  • Prostate Cancer Diagnosis and Treatment
  • Bioinformatics and Genomic Networks
  • Gene expression and cancer classification
  • Cancer, Lipids, and Metabolism
  • Molecular Biology Techniques and Applications
  • Photonic and Optical Devices
  • CRISPR and Genetic Engineering

Stanford University
2016-2025

University of Toronto
2013-2024

Mount Sinai Hospital
2010-2024

Lunenfeld-Tanenbaum Research Institute
2014-2024

University of Manchester
2002-2024

Public Health Ontario
2014-2024

Palo Alto University
2016-2024

University of Otago
2017-2024

Ganga Hospital
2013-2024

Occupational Cancer Research Centre
2013-2024

<h3>Importance</h3> The clinical management of<i>BRCA1</i>and<i>BRCA2</i>mutation carriers requires accurate, prospective cancer risk estimates. <h3>Objectives</h3> To estimate age-specific risks of breast, ovarian, and contralateral breast for mutation to evaluate modification by family history location. <h3>Design, Setting, Participants</h3> Prospective cohort study 6036<i>BRCA1</i>and 3820<i>BRCA2</i>female (5046 unaffected 4810 with or ovarian both at baseline) recruited in 1997-2011...

10.1001/jama.2017.7112 article EN JAMA 2017-06-20
Sang Lee Stephan Ripke Benjamin M. Neale Stephen V. Faraone Shaun Purcell and 95 more Roy H. Perlis Bryan Mowry Anita Thapar Michael E. Goddard Esther M. John Devin Absher Ingrid Agartz Huda Akil Farooq Amin Ole A. Andreassen Adebayo Anjorin Richard Anney Verneri Anttila Dan E. Arking Philip Asherson Maria Helena Pinto de Azevedo Lena Backlund Judith A. Badner Anthony Bailey Tobias Banaschewski Jack D. Barchas Michael R. Barnes Thomas B. Barrett Nicholas Bass Agatino Battaglia Michael J. Bauer Mónica Bayés Frank Bellivier Sarah E. Bergen Wade H. Berrettini Catalina Betancur Thomas Bettecken Joseph Biederman Elisabeth B. Binder Donald W. Black Douglas Blackwood Cinnamon S. Bloss Michael Boehnke Dorret I. Boomsma Gerome Breen René Breuer Richard Bruggeman Paul Cormican Nancy G. Buccola Jan K. Buitelaar William E. Bunney Joseph D. Buxbaum William Byerley Enda M. Byrne Sian Caesar Wiepke Cahn Rita M. Cantor Miguel Casas Aravinda Chakravarti Kimberly Chambert Khalid Choudhury Sven Cichon C. Robert Cloninger David Collier Edwin H. Cook Hilary Coon Bru Cormand Aiden Corvin William Coryell David W. Craig Ian Craig Jennifer Crosbie Michael L. Cuccaro David Curtis Darina Czamara Susmita Datta Géraldine Dawson Richard Day Eco J. C. de Geus Franziska Degenhardt Srdjan Djurovic Gary Donohoe Alysa E. Doyle Jubao Duan Frank Dudbridge Eftichia Duketis Richard P. Ebstein Howard J. Edenberg Josephine Elia Sean Ennis Bruno Étain Ayman H. Fanous Anne Farmer I. Nicol Ferrier Matthew Flickinger Éric Fombonne Tatiana Foroud Josef Frank Barbara Franke Christine Fraser

10.1038/ng.2711 article EN Nature Genetics 2013-08-11

Cross-talk between human epidermal growth factor receptors and hormone receptor pathways may cause endocrine resistance in breast cancer. This trial evaluated the effect of adding lapatinib, a dual tyrosine kinase inhibitor blocking 2 (HER2), to aromatase letrozole as first-line treatment (HR) -positive metastatic cancer (MBC).Postmenopausal women with HR-positive MBC were randomly assigned daily (2.5 mg orally) plus lapatinib (1,500 or placebo. The primary end point was progression-free...

10.1200/jco.2009.23.3734 article EN Journal of Clinical Oncology 2009-09-29
Ganna Chornokur Hui‐Yi Lin Jonathan P. Tyrer Kate Lawrenson Joe Dennis and 95 more Ernest K. Amankwah Xiaotao Qu Ya-Yu Tsai Heather Jim Zhihua Chen Y. Ann Chen Jennifer Permuth‐Wey Katja K.H. Aben Hoda Anton‐Culver Natalia Antonenkova Fiona Bruinsma Elisa V. Bandera Yukie T. Bean Matthias W. Beckmann Maria Bisogna Line Bjørge Natalia Bogdanova Louise A. Brinton Angela Brooks‐Wilson Clareann H. Bunker Ralf Bützow Ian Campbell Karen Carty Jenny Chang‐Claude Linda S. Cook Daniel W. Cramer Julie M. Cunningham Cezary Cybulski Agnieszka Dansonka‐Mieszkowska Andreas du Bois Evelyn Despierre Ed Dicks Jennifer A. Doherty Thilo Dörk Matthias Dürst Douglas F. Easton Diana Eccles Robert P. Edwards Arif B. Ekici Peter A. Fasching Brooke L. Fridley Yu‐Tang Gao Aleksandra Gentry‐Maharaj Graham G. Giles Rosalind Glasspool Marc T. Goodman Jacek Gronwald Patricia Harrington Philipp Harter Alexander Hein Florian Heitz Michelle A.T. Hildebrandt Peter Hillemanns Claus Høgdall Estrid Høgdall Satoyo Hosono Anna Jakubowska Allan Jensen Bu‐Tian Ji Beth Y. Karlan Linda E. Kelemen Mellissa Kellar Lambertus A. Kiemeney Camilla Krakstad Susanne K. Kjær Jolanta Kupryjańczyk Diether Lambrechts Sandrina Lambrechts Nhu D. Le Alice W. Lee Shashi Lele Arto Leminen Jenny Lester Douglas A. Levine Dong Liang Boon Kiong Lim Jolanta Lissowska Karen H. Lu Jan Lubiński Lene Lundvall Leon F.A.G. Massuger Keitaro Matsuo Valerie McGuire Esther M. John Iain A. McNeish Usha Menon Roger L. Milne Francesmary Modugno Kirsten B. Moysich Roberta B. Ness Heli Nevanlinna Ursula Eilber Kunle Odunsi Sara H. Olson Irene Orlow

Background Defective cellular transport processes can lead to aberrant accumulation of trace elements, iron, small molecules and hormones in the cell, which turn may promote formation reactive oxygen species, promoting DNA damage expression key regulatory cancer genes. As uncontrolled proliferation are hallmarks cancer, including epithelial ovarian (EOC), we hypothesized that inherited variation genes contributes EOC risk. Methods In total, samples were obtained from 14,525 case subjects...

10.1371/journal.pone.0128106 article EN cc-by PLoS ONE 2015-06-19

Concern with health effects of extremely low frequency magnetic fields has been raised by epidemiologic studies childhood cancer in relation to proximity electric power distribution lines. This case-control study was designed assess the between residential exposure and development cancer. Eligible cases consisted all 356 residents five-county 1970 Denver, Colorado Standard Metropolitan Statistical Area aged 0–14 years who were diagnosed any form 1976 1983. Controls selected random digit...

10.1093/oxfordjournals.aje.a114943 article EN American Journal of Epidemiology 1988-07-01

Journal Article Prostate Cancer in Relation to Diet, Physical Activity, and Body Size Blacks, Whites, Asians the United States Canada Get access Alice S. Whittemore, Whittemore 1Department of Health Research Policy, Stanford University School MedicineStanford, Calif. Search for other works by this author on: Oxford Academic PubMed Google Scholar Laurence N. Kolonel, Kolonel 2Cancer Center Hawaii, Hawaii at ManoaHonolulu Anna H. Wu, Wu 3Department Preventive Medicine, Southern CaliforniaLos...

10.1093/jnci/87.9.652 article EN JNCI Journal of the National Cancer Institute 1995-05-03
Xiaohong R. Yang Jenny Chang‐Claude Ellen L. Goode Fergus J. Couch Heli Nevanlinna and 95 more Roger L. Milne Mia M. Gaudet Marjanka K. Schmidt Annegien Broeks Angela Cox Peter A. Fasching Rebecca Hein Amanda B. Spurdle Fiona M. Blows Kristy Driver Dieter Flesch‐Janys Judith Heinz Hans‐Peter Sinn Alina Vrieling Tuomas Heikkinen Kristiina Aittomäki Päivi Heikkilä Carl Blomqvist Jolanta Lissowska Beata Pepłońska Stephen J. Chanock Jonine D. Figueroa Louise A. Brinton Per Hall Kamila Czene Keith Humphreys Hatef Darabi Jianjun Liu Laura van ‘t Veer Flora E. van Leeuwen Irene L. Andrulis Gord Glendon Julia A. Knight Anna Marie Mulligan Frances P. O’Malley Nayana Weerasooriya Esther M. John Matthias W. Beckmann Arndt Hartmann Sebastian Weihbrecht David L. Wachter Sebastian M. Jud Christian R. Loehberg Laura Baglietto Dallas R. English Graham G. Giles Catriona McLean Gianluca Severi Diether Lambrechts T. Vandorpe Caroline Weltens Robert Paridaens Ann Smeets Patrick Neven Hans Wildiers Xianshu Wang Janet E. Olson Victoria Cafourek Zachary Fredericksen Matthew Kosel Celine M. Vachon Helen Cramp Daniel Connley Simon S. Cross Sabapathy P. Balasubramanian Malcolm Reed Thilo Dörk Michael Bremer Andreas Meyer Johann H. Karstens Aysun Ay Tjoung‐Won Park‐Simon Peter Hillemanns José Ignacio Arias Pérez Primitiva Menéndez Rodríguez Pilar Zamora Javier Benı́tez Yon‐Dschun Ko Hans‐Peter Fischer Ute Hamann Beate Pesch Thomas Brüning Christina Justenhoven Hiltrud Brauch Diana Eccles William Tapper Sue Gerty Elinor J. Sawyer Ian Tomlinson Angela Jones Michael J. Kerin Nicola Miller Niall McInerney Hoda Anton‐Culver Argyrios Ziogas

Previous studies have suggested that breast cancer risk factors are associated with estrogen receptor (ER) and progesterone (PR) expression status of the tumors.

10.1093/jnci/djq526 article EN JNCI Journal of the National Cancer Institute 2010-12-29

BRCA1 and BRCA2 mutations in general populations various types of cancers have not been well characterized. We investigated the presence these unselected patients with newly diagnosed incident ovarian cancer Ontario, Canada, respect to reported among their relatives.A population series 1171 between January 1, 1995, December 31, 1999, was screened for germline throughout genes. Screening involved testing common variants, then protein truncation long exons, denaturing gradient gel...

10.1093/jnci/djj465 article EN JNCI Journal of the National Cancer Institute 2006-12-05

A whole-genome admixture scan in 1,597 African Americans identified a 3.8 Mb interval on chromosome 8q24 as significantly associated with susceptibility to prostate cancer [logarithm of odds (LOD) = 7.1]. The increased risk because inheriting ancestry is greater men diagnosed before 72 years age (P < 0.00032) and may contribute the epidemiological observation that higher for greatest younger (and attenuates older age). same region was recently through linkage analysis cancer, followed by...

10.1073/pnas.0605832103 article EN Proceedings of the National Academy of Sciences 2006-09-01
Nasim Mavaddat Daniel Barrowdale Irene L. Andrulis Susan M. Domchek Diana Eccles and 95 more Heli Nevanlinna Susan J. Ramus Amanda B. Spurdle Mark E. Robson Mark E. Sherman Anna Marie Mulligan Fergus J. Couch Christoph Engel Lesley McGuffog Sue Healey Olga M. Sinilnikova Melissa C. Southey Mary Beth Terry David E. Goldgar Frances P. O’Malley Esther M. John Ramūnas Janavičius Laima Tihomirova Thomas van Overeem Hansen Finn C. Nielsen Ana Osório Alexandra Stavropoulou Javier Benı́tez Siranoush Manoukian Bernard Peissel Monica Barile Sara Volorio Barbara Pasini Riccardo Dolcetti Anna Laura Putignano Laura Ottini Paolo Radice Ute Hamann Muhammad Usman Rashid Frans B.L. Hogervorst Mieke Kriege Rob B. van der Luijt Susan Peock Debra Frost D. Gareth Evans Carole Brewer Lisa Walker Mark T. Rogers Lucy Side Catherine Houghton JoEllen Weaver Andrew K. Godwin Rita K. Schmutzler Barbara Wappenschmidt Alfons Meindl Karin Kast Norbert Arnold Dieter Niederacher Christian Sutter Helmut Deißler Doroteha Gadzicki Sabine Preisler‐Adams Raymonda Varon-Mateeva Ines Schönbuchner Heidrun Gevensleben Dominique Stoppa‐Lyonnet Muriel Belotti Laure Barjhoux Claudine Isaacs Beth N. Peshkin Trinidad Caldés Miguel de la Hoya Carmen Cañadas Tuomas Heikkinen Päivi Heikkilä Kristiina Aittomäki Ignacio Blanco Conxi Lázaro Joan Brunet Bjarni A. Agnarsson Aðalgeir Arason Rósa B. Barkardóttir Martine Dumont Jacques Simard Marco Montagna Simona Agata Emma D’Andrea Max Yan Stephen B. Fox Timothy R. Rebbeck Wendy S. Rubinstein Nadine Tung Judy E. Garber Xianshu Wang Zachary Fredericksen V. Shane Pankratz Noralane M. Lindor Csilla I. Szabo Kenneth Offit Rita A. Sakr

Abstract Background: Previously, small studies have found that BRCA1 and BRCA2 breast tumors differ in their pathology. Analysis of larger datasets mutation carriers should allow further tumor characterization. Methods: We used data from 4,325 2,568 to analyze the pathology invasive breast, ovarian, contralateral cancers. Results: There was strong evidence proportion estrogen receptor (ER)-negative decreased with age at diagnosis among (P-trend = 1.2 × 10−5), but increased BRCA2, 6.8 10−6)....

10.1158/1055-9965.epi-11-0775 article EN Cancer Epidemiology Biomarkers & Prevention 2012-01-01
Rosalind A. Eeles Ali Amin Al Olama Sara Benlloch Edward J. Saunders Daniel Leongamornlert and 95 more Malgorzata Tymrakiewicz Maya Ghoussaini Craig Luccarini Joe Dennis Sarah Jugurnauth-Little Tokhir Dadaev David E. Neal Freddie C. Hamdy Jenny Donovan Ken Muir Graham G. Giles Gianluca Severi Fredrik Wiklund Henrik Grönberg Christopher A. Haiman Fredrick R. Schumacher Brian E. Henderson Loı̈c Le Marchand Sara Lindstrӧm Peter Kraft David J. Hunter Susan M. Gapstur Stephen J. Chanock Sonja I. Berndt Demetrius Albanes Gerald L. Andriole Johanna Schleutker Maren Weischer Federico Canzian Elio Ríboli Timothy J. Key Ruth C. Travis Daniele Campa Sue A. Ingles Esther M. John Richard B. Hayes Paul D.P. Pharoah Nora Pashayan Kay‐Tee Khaw Janet L. Stanford Elaine A. Ostrander Lisa B. Signorello Stephen N. Thibodeau Dan Schaid Christiane Maier Walther Vogel Adam S. Kibel Cezary Cybulski Jan Lubiński Lisa Cannon‐Albright Hermann Brenner Jong Y. Park Radka Kaneva Jyotsna Batra Amanda B. Spurdle Judith A. Clements Manuel R. Teixeira Ed Dicks Andrew Lee Alison M. Dunning Caroline Baynes Don Conroy Melanie Maranian Shahana Ahmed Koveela Govindasami Michelle Guy Rosemary Wilkinson Emma Sawyer Angela Morgan David P. Dearnaley Alan Horwich Robert Huddart Vincent Khoo Christopher Parker Nicholas van As Christopher Woodhouse Alan Thompson Tim Dudderidge Chris Ogden Colin S. Cooper Artitaya Lophatananon Angela Cox Melissa C. Southey John L. Hopper Dallas R. English Markus Aly Jan Adolfsson Jiangfeng Xu Siqun L. Zheng Meredith Yeager Rudolf Kaaks W. Ryan Diver Mia M. Gaudet Mariana C. Stern Román Corral

10.1038/ng.2560 article EN Nature Genetics 2013-03-27
Timothy R. Rebbeck Nandita Mitra Fei Wan Olga M. Sinilnikova Sue Healey and 95 more Lesley McGuffog Sylvie Mazoyer Georgia Chenevix‐Trench Douglas F. Easton Antonis C. Antoniou Katherine L. Nathanson Yael Laitman Anya Kushnir Shani Paluch‐Shimon Raanan Berger Jamal Zidan Eitan Friedman Hans Ehrencrona Marie Stenmark‐Askmalm Zakaria Einbeigi Niklas Loman Katja Harbst Johanna Rantala Beatrice Melin Dezheng Huo Olufunmilayo I. Olopade Joyce Seldon Patricia A. Ganz Robert L. Nussbaum Salina Chan Kunle Odunsi Simon A. Gayther Susan M. Domchek Banu K. Arun Karen H. Lu Gillian Mitchell Beth Y. Karlan Christine Walsh Jenny Lester Andrew K. Godwin Harsh B. Pathak Eric A. Ross Mary B. Daly Alice S. Whittemore Esther M. John Alexander Miron Mary Beth Terry Wendy K. Chung David E. Goldgar Saundra S. Buys Ramūnas Janavičius Laima Tihomirova Nadine Tung Cecilia M. Dorfling Elizabeth J. van Rensburg Linda Steele Susan L. Neuhausen Yuan Chun Ding Bent Ejlertsen Anne–Marie Gerdes Thomas van Overeem Hansen Teresa Ramón y Cajal Ana Osório Javier Benı́tez Javier Godino María‐Isabel Tejada M. Durán Jeffrey N. Weitzel Kristie Bobolis Sharon Sand Annette Fontaine Antonella Savarese Barbara Pasini Bernard Peissel Bernardo Bonanni Daniela Zaffaroni Francesca Vignolo-Lutati Giulietta Scuvera Giuseppe Giannini Loris Bernard Maurizio Genuardi Paolo Radice Riccardo Dolcetti Siranoush Manoukian Valeria Pensotti Viviana Gismondi Drakoulis Yannoukakos Florentia Fostira Judy E. Garber Diana Torres Muhammad Usman Rashid Ute Hamann Susan Peock Debra Frost Radka Platte D. Gareth Evans Rosalind A. Eeles Rosemarie Davidson Diana Eccles Trevor Cole

Limited information about the relationship between specific mutations in BRCA1 or BRCA2 (BRCA1/2) and cancer risk exists.

10.1001/jama.2014.5985 article EN JAMA 2015-04-07
Rosalind A. Eeles Zsofia Kote‐Jarai Ali Amin Al Olama Graham G. Giles Michelle Guy and 95 more Gianluca Severi Kenneth Muir John L. Hopper Brian E. Henderson Christopher A. Haiman Johanna Schleutker Freddie C. Hamdy David E. Neal Jenny Donovan Janet L. Stanford Elaine A. Ostrander Sue A. Ingles Esther M. John Stephen N. Thibodeau Daniel J. Schaid Jong Y. Park Amanda B. Spurdle Judith A. Clements Joanne L. Dickinson Christiane Maier Walther Vogel Thilo Dörk Timothy R. Rebbeck Kathleen A. Cooney Lisa Cannon‐Albright Pierre O. Chappuis Pierre Hutter Maurice P. Zeegers Radka Kaneva Hongwei Zhang Yong‐Jie Lu William D. Foulkes Dallas R. English Daniel Leongamornlert Malgorzata Tymrakiewicz Jonathan J. Morrison Audrey Ardern‐Jones Amanda L. Hall Lynne T. O'Brien Rosemary Wilkinson Edward J. Saunders Elizabeth Page Emma J Sawyer Stephen M. Edwards David P. Dearnaley Alan Horwich Robert Huddart Vincent Khoo Christopher Parker Nicholas van As Christopher Woodhouse Alan Thompson Tim Christmas Chris Ogden Colin S. Cooper Melissa C. Southey Artitaya Lophatananon Jo‐Fen Liu Laurence N. Kolonel Loı̈c Le Marchand Tiina Wahlfors Teuvo L.J. Tammela Anssi Auvinen Sarah J. Lewis Angela Cox Liesel M. FitzGerald Joseph S. Koopmeiners Danielle M. Karyadi Erika M. Kwon Mariana C. Stern Román Corral Amit D. Joshi Ahva Shahabi Shannon K. McDonnell Thomas A. Sellers Julio M. Pow‐Sang Suzanne K. Chambers Joanne F. Aitken Robert A. Gardiner Jyotsna Batra Mary Anne Kedda Felicity Lose Andrea Polanowski Briony Patterson Jürgen Serth Andreas Meyer Manuel Luedeke Klara Stefflova Anna M. Ray Ethan M. Lange James M. Farnham Humera Khan Chavdar Slavov A. Mitkova Guangwen Cao

10.1038/ng.450 article EN Nature Genetics 2009-09-20
Fergus J. Couch Xianshu Wang Lesley McGuffog Andrew Lee Curtis Olswold and 95 more Karoline B. Kuchenbaecker Penny Soucy Zachary Fredericksen Daniel Barrowdale Joe Dennis Mia M. Gaudet Ed Dicks Matthew Kosel Sue Healey Olga M. Sinilnikova Adam F. Lee François Bacot Daniel Vincent Frans B. L. Hogervorst Susan Peock D Stoppa-Lyonnet Anna Jakubowska kConFab Investigators Paolo Radice Rita Katharina Schmutzler Susan M. Domchek Marion Piedmonte Christian F. Singer Eitan Friedman Mads Thomassen Thomas van Overeem Hansen Susan L. Neuhausen Csilla I. Szabo Ignacio Blanco Mark H. Greene Beth Karlan Judy E. Garber Catherine M. Phelan Jeffrey N. Weitzel Marco Montagna Edith Olah Irene L. Andrulis Andrew K. Godwin Drakoulis Yannoukakos David E. Goldgar Trinidad Caldés Heli Nevanlinna Ana Osório Mary Beth Terry Mary B. Daly Elizabeth J. van Rensburg Ute Hamann Susan J. Ramus Amanda Ewart Toland Maria A. Caligo Olufunmilayo I. Olopade Nadine Tung Kathleen Claes Mary Beattie Melissa C. Southey Evgeny N. Imyanitov Marc Tischkowitz Ramūnas Janavičius Esther M. John Ava Kwong Orland Dı́ez Judith Balmañà Rósa B. Barkardóttir Banu K. Arun Gad Rennert Soo‐Hwang Teo Patricia A. Ganz Ian Campbell Annemarie H. van der Hout Carolien H.M. van Deurzen Caroline Seynaeve E. Gómez Flora E. van Leeuwen Hanne Meijers‐Heijboer Gilles Thomas Margreet G. E. M. Ausems Marinus J. Blok Marjolijn J. L. Ligtenberg Matti A. Rookus Peter Devilee Senno Verhoef Theo A.M. van Os Juul T. Wijnen D Frost Ian O. Ellis Elena Fineberg Radka Platte D. Gareth Evans Louise Izatt Rosalind A. Eeles Julian Adlard Diana Eccles Jackie Cook Carole Brewer Fiona Douglas

BRCA1-associated breast and ovarian cancer risks can be modified by common genetic variants. To identify further risk-modifying loci, we performed a multi-stage GWAS of 11,705 BRCA1 carriers (of whom 5,920 were diagnosed with 1,839 cancer), replication in an additional sample 2,646 carriers. We identified novel risk modifier locus at 1q32 for (rs2290854, P = 2.7×10−8, HR 1.14, 95% CI: 1.09–1.20). In addition, two loci: 17q21.31 (rs17631303, 1.4×10−8, 1.27, 1.17–1.38) 4q32.3 (rs4691139,...

10.1371/journal.pgen.1003212 article EN cc-by PLoS Genetics 2013-03-27
Coming Soon ...